Exciting News from Pharmidex!
December 6, 2024
Exciting News from
Pharmidex!
We’re delighted to share that
Martin Barrett, our Head of Business Development, will be representing
Pharmidex at the
British Neuroscience Association (BNA) 2024 Festive Symposium: "The Resilient Brain",
Taking place on Tuesday, 10th December 2024, from 10:00 AM to 6:00 PM at The Metropolitan Hotel, Leeds, UK.
As a proud Silver Sponsor of this event, Pharmidex is dedicated to supporting cutting-edge neuroscience and fostering meaningful collaborations. Martin is eager to meet with attendees, discuss shared goals, and explore opportunities to collaborate on innovative projects that advance the field of neuroscience.
Let’s connect, share insights, and pave the way for impactful partnerships!
📅 Event Details: (https://lnkd.in/eiPYk9hv)
We look forward to seeing you there!

#Pharmidex #Neuroscience #Collaboration #Innovation #BNA2024

We’re pleased to share that Janette Dalay Robertson , Business Development Manager at Pharmidex , will attend the DDW Turning Science into Business Symposium 2025 on Tuesday, 4th November, at the The Francis Crick Institute , London. Janette looks forward to connecting with industry leaders and exploring new collaboration opportunities.

We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.




